Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients

Authors
Publication date
3 March 2021
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    İstanbul Üniversitesi Açık Erişim Sistemi

    redirect
    oaioai:http://acikerisim.istanbul...
    Last time updated on 19/10/2022